McKesson executives reaped personal gains from generics price-fixing scheme, lawsuit claims
admin 29th May 2019 Uncategorised 0So far, the massive generic drug price-fixing probe has seemingly centered on the drugmakers themselves. Now, an investor lawsuit says drug distribution giant McKesson is in the mix, too—and that executives personally profited off the scheme. More: McKesson executives reaped
read more